Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
20
CDLX Quote, Financials, Valuation and Earnings
Last price:
$1.20
Seasonality move
:
-11.16%
Day range:
$1.05 - $1.24
52-week range:
$0.85 - $4.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.25x
P/B ratio:
1.15x
Volume:
1M
Avg. volume:
815.8K
1-year change:
-68.48%
Market cap:
$64.9M
Revenue:
$278.3M
EPS (TTM):
-$2.10
Analysts' Opinion
-
Consensus RatingCardlytics, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $1.63, Cardlytics, Inc. has an estimated upside of 50.46% from its current price of $1.22.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.50 representing 100% downside risk from its current price of $1.22.
Fair Value
-
According to the consensus of 4 analysts, Cardlytics, Inc. has 50.46% upside to fair value with a price target of $1.63 per share.
CDLX vs. S&P 500
-
Over the past 5 trading days, Cardlytics, Inc. has overperformed the S&P 500 by 0.45% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cardlytics, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cardlytics, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Cardlytics, Inc. reported revenues of $52M.
Earnings Growth
-
Cardlytics, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Cardlytics, Inc. reported earnings per share of -$1.36.
Enterprise value:
235.9M
EV / Invested capital:
1.09x
Price / LTM sales:
0.25x
EV / EBIT:
--
EV / Revenue:
0.94x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
-12.74x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$114.4M
Return On Assets:
-30.53%
Net Income Margin (TTM):
-44.12%
Return On Equity:
-214.96%
Return On Invested Capital:
-40.63%
Operating Margin:
-18.63%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $302.5M | $293.5M | $251.2M | $67.1M | $52M | |
| Gross Profit | $124.7M | $130.7M | $114.4M | $29.4M | $23.6M | |
| Operating Income | -$81.1M | -$63.1M | -$49.8M | -$16.9M | -$9.7M | |
| EBITDA | -$50.7M | -$34.7M | -$23.1M | -$9.3M | -$2.7M | |
| Diluted EPS | -$12.25 | -$6.11 | -$2.10 | -$2.90 | -$1.36 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $335.5M | $249.1M | $205.6M | $183.3M | $140.7M | |
| Total Assets | $1.2B | $1.1B | $634.9M | $399.4M | $292.8M | |
| Current Liabilities | $274.5M | $254.9M | $179.5M | $155.9M | $123.7M | |
| Total Liabilities | $536M | $485.8M | $409.6M | $329.7M | $297.5M | |
| Total Equity | $688.6M | $580.5M | $225.3M | $69.7M | -$4.7M | |
| Total Debt | $189.6M | $230.8M | $230.1M | $173.8M | $173.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$16.2M | -$8.9M | -$846K | $1.4M | $1.7M | |
| Cash From Investing | -$11.8M | -$16M | -$17.1M | -$5.3M | -$4.5M | |
| Cash From Financing | -$20.3M | $1.7M | -$5.2M | -$388K | -- | |
| Free Cash Flow | -$28.1M | -$27.4M | -$18.5M | -$3.9M | -$2.7M | |
CDLX
Sector
Market Cap
$64.9M
$51M
Price % of 52-Week High
29.67%
62.77%
Dividend Yield
0%
0%
Shareholder Yield
0.08%
1.13%
1-Year Price Total Return
-72.02%
-5.42%
Beta (5-Year)
1.094
0.326
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.05
200-day SMA
Sell
Level
$1.70
Bollinger Bands (100)
Sell
Level
1.01 - 2.05
Chaikin Money Flow
Buy
Level
46.7M
20-day SMA
Buy
Level
$1.13
Relative Strength Index (RSI14)
Buy
Level
51.40
ADX Line
Sell
Level
35.14
Williams %R
Neutral
Level
-59.1099
50-day SMA
Sell
Level
$1.46
MACD (12, 26)
Sell
Level
-0.10
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
151.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.0195)
Sell
CA Score
(Annual)
Level (-2.155)
Buy
Beneish M-Score
(Annual)
Level (-4.878)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.6341)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
Stock Forecast FAQ
In the current month, CDLX has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CDLX average analyst price target in the past 3 months is $1.63.
-
Where Will Cardlytics, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cardlytics, Inc. share price will rise to $1.63 per share over the next 12 months.
-
What Do Analysts Say About Cardlytics, Inc.?
Analysts are divided on their view about Cardlytics, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardlytics, Inc. is a Sell and believe this share price will drop from its current level to $1.50.
-
What Is Cardlytics, Inc.'s Price Target?
The price target for Cardlytics, Inc. over the next 1-year time period is forecast to be $1.63 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is CDLX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cardlytics, Inc. is a Hold. 4 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CDLX?
You can purchase shares of Cardlytics, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardlytics, Inc. shares.
-
What Is The Cardlytics, Inc. Share Price Today?
Cardlytics, Inc. was last trading at $1.20 per share. This represents the most recent stock quote for Cardlytics, Inc.. Yesterday, Cardlytics, Inc. closed at $1.22 per share.
-
How To Buy Cardlytics, Inc. Stock Online?
In order to purchase Cardlytics, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CDLX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CDLX
Sector
P/E ratio
--
16.33x
PEG ratio
-0.09x
0.00x
P/B ratio
1.15x
1.30x
Price / LTM sales
0.25x
0.85x
Growth Metrics
CDLX
Sector
Revenue growth
-22.41%
1.07%
Earnings growth
53.18%
9.34%
Revenue (5-year growth)
5.75%
1.1%
Earnings forecast
-$0.15
$0.05
Profitability
CDLX
Sector
Profitability FY 2024
$124.8M
$109.7M
Return on invested capital
-40.63%
0.48%
Return on assets
-30.53%
-0.17%
Return on equity
-214.96%
1.42%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Feb
4
Balance Sheet
CDLX
Sector
Total cash
$44M
$72.3M
Short term investments
--
$24.7M
Total assets
$392.7M
$549.2M
Long term debt
$173.7M
$12.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
